Tag: IPO

Browse our exclusive articles!

Grammarly Co-founder: No Immediate Plans for IPO Despite $13B Valuation

Grammarly, the Canadian and Ukrainian AI firm renowned for its AI-powered writing assistance software, currently has no plans for an IPO despite its $13 billion valuation. Discover why Grammarly prefers to focus on innovation and writing solutions.

Chinese chip startup Biren plans Hong Kong IPO this year

Shanghai Biren Intelligent Technology Co. considering Hong Kong IPO to meet growing demand for AI chips as Nvidia products are banned.

Inside Reddit’s Path to IPO: Employees Cope with Constant Pivots and Predict More Manager Departures Amid Flattening

Inside Reddit's challenging journey to an IPO, facing internal issues and changes. Learn about trust in leadership, cost control, and streamlining operations.

Chatty with ChatGPT Daily: SoftBank’s CEO Masayoshi Son Admits to being a ‘Heavy User’

Discover SoftBank CEO's innovative investment strategy with AI using ChatGPT. Learn how the company plans to recover from recent setbacks. Read more now.

Rising Up: The Story of a Wall Street Prodigy

Get inspired by the success story of Soeren Kuenzel, who rose to the top of Citadel Securities' foreign exchange team at just 31 years old. Learn about the importance of problem-solving in the financial industry and other news in this article.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img